Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It was my understanding that Carter/REVO surrendered all patent rights to Eyetalk365. Is it not true that Eyetalk365 is owned by a fellow whose name is Ross Hefer?
Well, maybe it's true that REVO is worthless. But what is puzzling to me is why this zombie company is still hanging around. Why don't REVO just dry up and go away, why are they still here?
Well, I don't disagree with you except for one assertion, and that's regarding your take on managerial incompetence. I don't ,think they are incompetent, at all. This behavior is calculated and executed as planned by these people. I don't know for sure why this is being done, but I have my theory; I guess, much like many others on this board. Again, I don't disagree with you, but I do think expectations must be tamped down a bit when BIEL, or the FDA is involved. That's It!!
GLTA!!!
Well, sorry to break the news to you, but Monday is going to bring zilch, nada, a big fat nothing! My goodness! By now, everyone who frequent this board should have gotten it by now. IMO, BIEL has made it abundantly clear, they don't care one iota about shareholders' concerns. Thus, you can call, email, or send a carrier pigeon, if you think that will work for you, but the response will be the same, silence. Guaranteed!! Oh, yes, may I interject another point. IMO, that recent Additional Request for Information BIEL received from the FDA is just another stall tactic. So, be prepared to wait an additional 90 to 120 days before hearing anything from the FDA. Sorry!!
GLTA!!!
P.S. Of course, I hope I'm wrong about all of this, but I don't think so!!
Yes, your point is well made if you are referring to the barring of AW and possibly others from conducting specific company activities as resulting from the SEC ruling. Ok! Got It! But, what I'm alluding to is the previously established salaries, stock holding, etc., which the CEO, and his senior officials continue to enjoy. So, my contention is this information should be readily available for public examination, shouldn't it?
GLTA!!!
You Got it!
GLTA!!!
Quote: "The FDA is just another government agency that can't get out of it's own way." Well, IMO, that's not altogether true, for the FDA has been around since, June 30, 1906 (i.e., 112 years). The FDA knows exactly what they are doing. As I have posted previously, just Follow The Money. The FDA has hordes of lobbyists crawling all over them, as any other important government agency. This stuff isn't rocket science folks.
GLTA!!!
As a publicly owned business concern, is it correct that BIEL must make public the salaries, stock trading activity, etc., of its senior officials? If the aforementioned question is answered in the affirmative, then does anyone on this board know where this information can be obtained?
GLTA!!!
Who knows what that CEO's thoughts, or intentions are!! Just Weird!!
GLTA!!!
Of course, BIEL is an accident waiting to happen, but that dosn't excuse the FDA from their duplicity behavior, IMO. You can bet, they have an agenda, as per this matter, IMO. You can take that to the bank, IMO!!
Follow the Money!!
GLTA!!!
IMO, BIEL should have taken it's case to the public a long time ago. You can only do this with Ads. Ads that clearly delineate your product's wares, and project future intentions regarding product availability to the public. These pronouncements should include FDA involvement in successfully getting this truly needed product to the public. So, let the FDA explain why they are holding this effective product hostage. Well, maybe I'm all wet, but IMHO, a lot of this stuff is elementary. Huh! Mr. Watson!
GLTA!!!
It's clear what the FDA is doing. They wait until almost the actual due date to announce their decision on clearance, then they drop another Request for Additional Information on BIEL. As I understand it, the FDA has new leadership, or, will have it soon. But, IMO, it makes "no never mind", for the FDA has BIEL up a tree, so to speak, and they are no going to relent, apparently. Thus, the "Thwart BIEL Doctrine" is living deep in the bowels of the FDA. IMO, this is a clear tactic of attrition. Of course, BIEL has no money for lobbyists to feed palms, so it's essential that BIEL has friends on the highest plateaus in government to assist them with get this done. But apparently, they don't have those bases covered either. It's your politics BIEL, or the lack of it!! As I stated in one of my earlier posts, if BIEL doesn't get clearance within 90 days of 510(k) submission, they won't get it at all. Unfortunately, it appears this situation is headed in that direction. Sad!! Real Sad!!
GLTA!!!
DB, there is something operating here that's a bit more deliberate than just abject incompetence. Now consider the supposed capabilities of Mr. Nalepka. By all accounts, he's a pretty competent fellow. His educational preparation and his past professional successes are reasonably impressive, as thus, put on display by his resume. So, from my vantage point, it would be a bit unreasonable to label him as an incompetent. However, AW could be dominating him. Thus, neutering Keith's ideas and his vision regarding what path the company should take for success (i.e., from a Sales and Marketing standpoint). IMO, yes, there is something very wrong with how this company is being managed. However, IMO, if Mr. Keith would assert himself a bit more, maybe he could be the linchpin of BIEL's success. Just Maybe!! Well, That's My Take!
GLTA!!!
Where did this information come from? Can you provide a link?
Thanks!
It appears to be recent! Well, if it is a new promo, then that's Great! Every little bit helps. But what's curious about this website's presentation, is there's no text highlighting FDA approval. I think BIEL should exploit that little detail as a conspicuous, selling nugget. Oh, well, what do I know!
GLTA!!!
Why don't they just advertise? Of course, it's apparent they don't have a well healed company budget, but they should be able to retrieve enough change from between the couch cushions to leverage an inexpensive Ad campaign, for starters. Subsequently, of course, when the upshot sales revenue starts to pour in, they will be able to grow their Ad budget, along with the company, as a whole. In fact, they could have done this a long time ago! One must ask, why didn't they? This is not rocket science folks. IMO, it's pretty obvious, BIEL's management has an ulterior motive for conducting business in this way!
GLTA!!!
Quote: "Whelan didn't fail in mainland Europe...he just didn't try", Bieliever, your words amount to a devastating indictment of BIEL's CEO, regarding his lack of focus and effort, thus, not putting forth the necessary marketing to sale his product. There is such a tremendous public need for an effective, non drug based analgesic medium, such as Actipatch. IMO, what's going on with this situation is a true travesty!
GLTA!!!
The Ad brigade at BIEL should be in full stride by now. Perhaps the "Big Man", Mr. AW, thinks advertising is an anachronism at the moment? Huh! Furthermore, this excuse being forever floated, in regards, to not have funds to advertise, well that's poppycock, IMO. A decent Ads campaign can be leveraged and launched today, if BIEL (i.e., AW) desired to do so, IMHO!! Heck, they could have dedicated a fraction of a day's worth of equity dilution and jump-started a serious, serious, serious, Ads campaign long ago, if that's what they desired. Oh, Come On People, Let's Get Serious!!
GLTA!!!
Well, to mix old adages, “When you fail, try, try , try again, while using the same approach, but expecting different results.", is where we are at this time. Now to consider the FDA as the beginning and end all for BIEL's success is wishful thinking and utter folly, may I add. Ok, let's say BIEL gets its clearance(s) from the FDA this time around, but IMO, this will result in a temporary amplitude in BIEL's stock PPS, as we have seen in the past. IMHO, this short-term rise of the PPS will be the offspring of elevated interest of people "in the know" (i.e., investors), to trade in BIEL' stock. However, when the "rational exuberance" wares off without the underpinning of increased sales, the PPS will retreat back to the depressing depths which we are experiences at this very moment, IMO. BIEL must advertise, advertise, advertise, and advertise again to sustain growth. IMO, this is essential because of its fledgling status as a business concern, in particular. Of course, this is quite elementary Mr. Watson! Well, That's My Take!!
GLTA!!!
If the FDA doesn't make good on BIEL's latest 510(k) clearance submission within the next couple weeks, then IMO, it won't happen.
GLTA!!!
If BIEL wanted to increase sales in a hurry, they would only have to produce Ads (i.e., relatively cheap TV/radio ads at that), and CVS would sell out practically overnight. Pretty Much guaranteed! So one must ask, why aren't they doing this? Something is a skew, but what?!!!!!!!!
GLTA!!!
By the by, those financial numbers should be obtained as a result of basic DD. One shouldn't have to dig deep to gain info of that nature!!
GLTA!!!
Well, Ok! But, to repeat the question... where did those numbers come from?
Where did you get those numbers?
See below:
The following data gathered from- YaHoo Finance -
BioElectronics Corporation (BIEL)
At close: April 12 3:35PM EDT
Major Holders
Currency in USD
Breakdown
0.00% % of Shares Held by All Insider
0.00% % of Shares Held by Institutions
0.00% % of Float Held by Institutions
1 Number of Institutions Holding Shares
Art, Hear! Hear! I agree wholeheartedly!
GLTA!!!
If I may chime in once more from the Friendly Corner of the Peanut Gallery. Now, I'm sure most of us are familiar with the following tropes. Thus, in real estate it's Location, Location, Location! Another, It's The Economy Stupid! Well, in BIEL's case, it should be "Get Your Politics in Order Numbskull!". This should have been one of their business "Code's of Conduct", a long time ago, especially, if they didn't want any problem presented by the gatekeeper, i.e., the FDA. That's My Take!!
GLTA!!!
With this post, I come in out of the cold for a brief moment, and thus, suspend my self imposed exile from board participation. My reason for doing so is to bring prospective regarding to cost numbers associated with BIEL's losses over the years. The losses are substantial, but they are representative of expected cost demands/losses of bringing a product like Actipatch to market; thus, so posited by the article presented below:
"The average cost to bring a low-to-moderate 510(k) product from concept to market is $31 million. High-risk PMA costs averaged $94 million, with $75 million spent on FDA-linked stages. Article: May 25, 2017"
So, there you have it! So, Auf wiedersehen, once again!
As Always, GLTA!!!
Well, I think the BIEL conundrum has out lasted me. Maybe it's high time that I cease and desist, in regards to trying to crack the code of the BIEL riddle, wrapped in an enigma mystery, and posting my ruminations about same. Furthermore, it's kinda humbling to come to the realization that myself and, if I may take liberty to say, everyone else on this board have been just spinning our wheels, trying to figure this mess out. For there is no logic associated with BIEL's management's behavior, IMO. None! It makes no sense, at all, why this product is not already a household name for millions, upon millions of pain sufferers throughout the world, let alone this country. So, I'll keep tabs on board activities from time to time but won't chime in, however, until state of affairs which are associated with this company have evolved into some semblance of normalcy, if you will. So, with all that out of the way, Auf Wiedersehen, Everybody!!
And GLTA!!!
Well, stocking 2, maybe 3 Actipatch devices, per store, is just not going to get it done!
GLTA!!!
BIEL needs more than a PR here and there, they need general, comprehensive, serious advertisement. Full Stop!!
GLTA!!!
JGD, Yes! Much of the material you post about Actipatch is great information. Your post larding the healing capacity of RecoveryRx, to which this post is in reply, is quite impressive. But for sure, scattered, one-off articles, or even favorable posts presented on this board won't make it happen for this product, or BIEL, IMHO. There must be a turn, and soon! Well, that's my take!!
GLTA!!!
As a result of querying a number of CVS store inventories, I've never seem more than 3 Actipatch units available. Does anybody have an idea why that is? By having no more than 3 units per store available for sell is just not going to cut it. If this product doesn't get advertised is a serious manner, then it's just not going to sell in a big way, period! I guess there is a strategy to all of this, but what is it?
Hmm!
GLTA!!!
Well, I guess a little levity can't hurt, considering!
GLTA!!!
"The Next Great News an Hour or Two After Market Open "... Please be specific! What are you talking about?
GLTA!!!
Nothing new! Sold on walmart.com by third party.
GLTA!!!
That's a roger! Great feedback, Thanks!
GLTA!!!
Why is it the stores only carry 2 to 3 products in their inventory at any given time? I guess that's the test limit, maybe. The inventory count at the store in my area shows 3 available, but the items couldn't be located. The store sales personnel suspects they were stolen. I guess there could be a plus or minus scenario attached to that situation. Huh! If you know what I mean!
GLTA!!!
I have an idea, but I rather not say just yet.
GLTA!!!
Something is wrong here and it's not because of abject, and rampant incompetence, IMO!
GLTA!!!
Well, yes, I agree with you. As I have stated for a number of months now, that BIEL is orchestrating this whole thing. There needs to be an independent, in depth investigation regarding this situation. IMO, the people at BIEL are committing malfeasance against their shareholders. BIEL, as a public business concern, has a fiduciary duty to its shareholders to protect and advance the financial interest of said shareholders, whom have invested in BIEL's stock. Something needs to be done about this before it's too late! Fact!!
GLTA!!!